Benlysta 400 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9GX2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,085
Award facts
- Contract value 100% obligated
- $11,084.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,084.88 to AmerisourceBergen Drug Corp for the supply of Benlysta 400 mg vials under a firm fixed-price contract. The award was made on December 22, 2025, with an ultimate completion date of January 14, 2026. This non-set-aside competitive award leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
Benlysta is a specialized biologic medication used in the treatment of systemic lupus erythematosus and other autoimmune conditions. This delivery order represents a routine pharmaceutical procurement transaction within AmerisourceBergen's comprehensive global pharmaceutical support vehicle with DLA, which enables the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract vehicle serves customers including the Defense Health Agency and U.S. Coast Guard, demonstrating the company's role as a key supplier for Department of Defense medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26F9GX2?
SPE2DR26F9GX2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26F9GX2 worth?
The government has obligated $11,085 on SPE2DR26F9GX2.
Is contract SPE2DR26F9GX2 an order under another contract?
Yes. SPE2DR26F9GX2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GX2 competed?
The extent of competition for SPE2DR26F9GX2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award